Physician profile
Bryan Khim
NPI 1598788762
$2,048.85
in general payments reported to CMS, 2019-2025
20 companies · $829 in 2025
The $829 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.39 · 2023: $539 · 2024: $664 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,014 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,013.61 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $290.93 | 2023-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $279.60 | 2021-2025 | Shingrix, Arexvy |
| Novo Nordisk INC | $183.89 | 2023-2025 | Ozempic, Rybelsus |
| Lundbeck LLC | $173.47 | 2024-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.93 | 2023-2025 | Jardiance |
| Esperion Therapeutics, INC. | $138.05 | 2023-2025 | Nexletol |
| Sumitomo Pharma America, INC. | $126.54 | 2023-2025 | Gemtesa |
| Otsuka America Pharmaceutical, INC. | $121.06 | 2023-2025 | Rexulti |
| Lilly USA, LLC | $98.92 | 2023-2025 | Jardiance, Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $82.52 | 2024-2025 | Farxiga |
| Pfizer INC. | $75.74 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.59 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $66.84 | 2024-2025 | |
| Aimmune Therapeutics, INC. | $49.46 | 2024-2025 | Zenpep |
| Eisai INC. | $25.51 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.84 | 2024 | Freestyle Libre 3 |
| Nestle Healthcare Nutrition INC. | $22.20 | 2023 | |
| Seqirus USA INC | $20.89 | 2025 | Flucelvax, Fluad |
| Exact Sciences Corporation | $18.59 | 2025 | The Cologuard Plus Collection Kit |
| Abbvie INC. | $18.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Khim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.